Roivant Sciences Ltd. Common Shares (ROIV) Stock Price, Quote & AI Analysis
Live ROIV stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Roivant Sciences Ltd. Common Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Roivant Sciences Ltd. Common Shares (ROIV), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Roivant Sciences Ltd. Common Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Roivant Sciences Ltd. Common Shares Overview
Company information
Company Overview
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Roivant Sciences Ltd. Common Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...